Clinical & Experimental Metastasis

, Volume 20, Issue 1, pp 59–68

Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

  • Michael S. Kinch
  • Kelly Carles-Kinch
Article

Abstract

Cancer is a disease of aberrant signal transduction. The expression and function of intracellular signaling pathways are frequently subverted as cells progress towards a metastatic phenotype. In particular, tyrosine kinases initiate powerful signals that govern many different aspects of cell behavior. In Recent studies have demonstrated that the EphA2 receptor tyrosine kinase is frequently overexpressed and functionally altered in aggressive tumor cells, and that these changes promote metastatic character. Herein, we provide an overview of our current understanding of EphA2, with emphasis upon the differential regulation of EphA2 expression and function. We also show that differential EphA2 expression and function may provide a unique opportunity for selective therapeutic targeting of EphA2 in metastatic disease.

EphA2 ephrin metastasis monoclonal antibody oncogene tyrosine kinase 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fidler IJ. Molecular Biology of Cancer: Invasion and Metastasis. In Devita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 5th ed., Philadelphia: Lippincott-Raven 1997; 135–52.Google Scholar
  2. 2.
    Lawrence JA, Steeg PS. Mechanisms of tumor invasion and metastasis. World J Urol 1996; 14: 124–30.Google Scholar
  3. 3.
    Price JE. Host-tumor interactions in the progression of breast cancer metastasis. In Vivo 1994; 8: 145–54.Google Scholar
  4. 4.
    Welch DR, Steeg PS, Rinker-Schaeffer CW. Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res 2000; 2: 408–16.Google Scholar
  5. 5.
    Folkman J. Angiogenesis and angiogenesis inhibition: An overview. EXS 1997; 79: 1–8.Google Scholar
  6. 6.
    Ruoslahti E. How cancer spreads. Sci Am 1996; 275: 72–7.Google Scholar
  7. 7.
    Ruoslahti E. Fibronectin and its integrin receptors in cancer. Adv Cancer Res 1999; 76: 1–20.Google Scholar
  8. 8.
    Zetter BR. Adhesion molecules in tumor metastasis. Semin Cancer Biol 1993; 4: 219–29.Google Scholar
  9. 9.
    Parise LV, Lee J, Juliano RL. New aspects of integrin signaling in cancer. Semin Cancer Biol 2000; 10: 407–14.Google Scholar
  10. 10.
    Yamada KM, Geiger B. Molecular interactions in cell adhesion complexes. Curr Opin Cell Biol 1997; 9: 76–85.Google Scholar
  11. 11.
    Schoenwaelder SM, Burridge K. Bidirectional signaling between the cytoskeleton and integrins. Curr Opin Cell Biol 1999; 11: 274–86.Google Scholar
  12. 12.
    Geiger B, Ayalon O. Cadherins. Annu Rev Cell Biol 1992; 8: 307–32.Google Scholar
  13. 13.
    Birchmeier C, Birchmeier W, Brand S. Epithelial-mesenchymal transitions in cancer progression. Acta Anatomica 1996; 156: 217–26.Google Scholar
  14. 14.
    Volberg T, Zick Y, Dror R et al. The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions. EMBO J 1992; 11: 1733–42.Google Scholar
  15. 15.
    Kinch MS, Clark GJ, Der CJ et al. Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J Cell Biol 1995; 130: 461–71.Google Scholar
  16. 16.
    Parsons JT, Martin KH, Slack JK et al. Focal adhesion kinase: A regulator of focal adhesion dynamics and cell movement. Oncogene 2000; 19: 5606–13.Google Scholar
  17. 17.
    Clark EA, King WG, Brugge JS et al. Integrin-mediated signals regulated by members of the rho family of GTPases. J Cell Biol 1998; 142: 573–86.Google Scholar
  18. 18.
    Patstone G, Maher PA. Phosphotyrosine-containing proteins are concentrated in differentiating cells during chicken embryonic development. Growth Factors 1993; 9: 243–52.Google Scholar
  19. 19.
    Kinch MS, Kilpatrick K, Zhong C. Identification of tyrosine phosphorylated adhesion proteins in human cancer cells. Hybridoma 1998; 17: 227–35.Google Scholar
  20. 20.
    Blume-Jensen P, Hunter T. Oncogenic kinase signaling. Nature 2001; 411: 355–65.Google Scholar
  21. 21.
    Pawson T., Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 1997; 278: 2075–80.Google Scholar
  22. 22.
    Jove JA, Hanafusa H. Cell transformation by the viral src gene. Annu Rev Cell Biol 1987; 3: 31–65.Google Scholar
  23. 23.
    Kinch MS, Burridge K. Altered adhesions in ras-transformed breast epithelial cells. Biochem Soc Trans 1995; 23: 446–50.Google Scholar
  24. 24.
    Zelinski DP, Zantek ND, Stewart JC et al. EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res 2001; 61: 2301–6.Google Scholar
  25. 25.
    Zantek ND, Walker-Daniels J, Stewart JC et al. MCF-10A-NeoST: A new cell system for studying cell-ECM and cell-cell interactions in breast cancer. Clin Cancer Res 2001; 7: 3640–8.Google Scholar
  26. 26.
    Walker-Daniels J, Coffman K, Azimi M et al. Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate 1999; 41: 275–80.Google Scholar
  27. 27.
    Zantek ND, Azimi M, Fedor-Chaiken M et al. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differentiation 1999; 10: 629–38.Google Scholar
  28. 28.
    Carles-Kinch K, Kilpatrick KE, Stewart JC et al. Antibody targeting of the EphA2 receptor tyrosine kinase on malignant carcinomas. Cancer Res 2001; 62: 2840–7.Google Scholar
  29. 29.
    Lindberg RA, Hunter T. cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases. Mol Cell Biol 1990; 10: 6316–24.Google Scholar
  30. 30.
    Gale NW, Yancopoulos GD. Ephrins and their receptors: A repulsive topic? Cell Tissue Res 1997; 290: 227–41.Google Scholar
  31. 31.
    Pasquale EB. The Eph family of receptors. Curr Opin Cell Biol 1997; 9: 608–15.Google Scholar
  32. 32.
    Shao H, Pandey A, O’Shea KS et al. Characterization of B61, the ligand for the Eck receptor protein-tyrosine kinase. J Biol Chem 1995; 270: 5636–41.Google Scholar
  33. 33.
    Bartley TD, Hunt RW, Welcher AA et al. B61 is a ligand for the ECK receptor protein-tyrosine kinase. Nature 1994; 368: 558–60.Google Scholar
  34. 34.
    Hunter T, Lindberg RA, Middlemas DS et al. Receptor protein tyrosine kinases and phosphatases. Cold Spring Harbor Symp Quant Biol 1992; 57: 25–41.Google Scholar
  35. 35.
    Gale NW, Holland SJ, Valenzuela DM et al. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 1996; 17: 9–19.Google Scholar
  36. 36.
    Davis S, Gale NW, Aldrich TH et al. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 1994; 266: 816–9.Google Scholar
  37. 37.
    Eph Nomenclature Committee (Flanagan JG, Gale NW, Hunter T et al.) Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee. Cell 1997; 90: 403–4.Google Scholar
  38. 38.
    Lemke G. A coherent nomenclature for Eph receptors and their ligands. Mol Cell Neurosci 1997;9: 331–2.Google Scholar
  39. 39.
    Hunter T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Phil Trans R Soc London Ser B Biol Sci 1998; 353: 583–605.Google Scholar
  40. 40.
    Holland SJ, Peles E, Pawson T et al. Cell-contact-dependent signalling in axon growth and guidance: Eph receptor tyrosine kinases and receptor protein tyrosine phosphatase beta. Curr Opin Neurobiol 1998; 8: 117–27.Google Scholar
  41. 41.
    Orioli D., Klein R. The Eph receptor family: Axonal guidance by contact repulsion. Trends Genet 1997; 13: 354–9.Google Scholar
  42. 42.
    Wang HU, Anderson DJ. Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron 1997; 18: 383–96.Google Scholar
  43. 43.
    Tessier-Lavigne M. Eph receptor tyrosine kinases, axon repulsion, and the development of topographic maps. Cell 1995; 82: 345–8.Google Scholar
  44. 44.
    Weinstein DC, Rahman SM, Ruiz JC et al. Embryonic expression of eph signalling factors in Xenopus. Mech Dev 1996; 57: 133–44.Google Scholar
  45. 45.
    Bovenkamp DE, Greer P. Novel Eph-family receptor tyrosine kinase is widely expressed in the developing zebrafish nervous system. Dev Dynam 1997; 209: 166–81.Google Scholar
  46. 46.
    Helbling PM, Tran CT, Brandli AW. Requirement for EphA receptor signaling in the segregation of Xenopus third and fourth arch neural crest cells. Mech Dev 1998; 78: 63–79.Google Scholar
  47. 47.
    Chen J, Ruley HE. An enhancer element in the EphA2 (Eck) gene sufficient for rhombomere-specific expression is activated by HOXA1 and HOXB1 homeobox proteins. J Biol Chem 1998; 273: 24670–5.Google Scholar
  48. 48.
    Mori T, Wanaka A, Taguchi A et al. Differential expressions of the eph family of receptor tyrosine kinase genes (sek, elk, eck) in the developing nervous system of the mouse. Brain Res 1995; 29: 325–35.Google Scholar
  49. 49.
    Naruse-Nakajima C, Asano M, Iwakura Y. Involvement of EphA2 in the formation of the tail notochord via interaction with ephrinA1. Mech Dev 2001; 102: 95–105.Google Scholar
  50. 50.
    Connor RJ, Menzel P, Pasquale EB. Expression and tyrosine phosphorylation of Eph receptors suggest multiple mechanisms in patterning of the visual system. Dev Biol 1998; 193: 21–35.Google Scholar
  51. 51.
    Sefton M, Araujo M, Nieto MA. Novel expression gradients of Ephlike receptor tyrosine kinases in the developing chick retina. Dev Biol 1997; 188: 363–8.Google Scholar
  52. 52.
    Marcus RC, Gale NW, Morrison ME et al. Eph family receptors and their ligands distribute in opposing gradients in the developing mouse retina. Dev Biol 1996; 180: 786–9.Google Scholar
  53. 53.
    Magal E, Holash JA, Toso RJ et al. B61, a ligand for the Eck receptor protein-tyrosine kinase, exhibits neurotrophic activity in cultures of rat spinal cord neurons. J Neurosci Res 1996; 43: 735–44.Google Scholar
  54. 54.
    Chen J, Nachabah A, Scherer C et al. Germ-line inactivation of the murine Eck receptor tyrosine kinase by gene trap retroviral insertion. Oncogene 1996; 12: 979–88.Google Scholar
  55. 55.
    Ganju P, Shigemoto K, Brennan J et al. The Eck receptor tyrosine kinase is implicated in pattern formation during gastrulation, hindbrain segmentation and limb development. Oncogene 1994; 9: 1613–24.Google Scholar
  56. 56.
    Lickliter JD, Smith FM, Olsson JE et al. Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases. PNAS 1996; 93: 145–50.Google Scholar
  57. 57.
    Andres AC, Reid HH, Zurcher G et al. Expression of two novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis. Oncogene 1994; 9: 1461–7.Google Scholar
  58. 58.
    Andres AC, Zuercher G, Djonov V et al. Protein tyrosine kinase expression during the estrous cycle and carcinogenesis of the mammary gland. Int J Cancer 1995; 63: 288–96.Google Scholar
  59. 59.
    Berclaz G, Andres AC, Albrecht D et al. Expression of the receptor protein tyrosine kinase myk-1/htk in normal and malignant mammary epithelium. Biochem Biophys Res Commun 1996; 226: 869–75.Google Scholar
  60. 60.
    Easty DJ, Bennett DC. Protein tyrosine kinases in malignant melanoma. Melanoma Res 2000; 10: 401–11.Google Scholar
  61. 61.
    Easty DJ, Guthrie BA, Maung K et, 2000al. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. Cancer Res 1995; 55: 2528–32.Google Scholar
  62. 62.
    Easty DJ, Herlyn M, Bennett DC. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis. Int J Cancer 1995; 60: 129–36.Google Scholar
  63. 63.
    Ogawa K, Pasqualini R, Lindberg RA et, 2000al. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 2000; 19: 6043–52.Google Scholar
  64. 64.
    Rosenberg IM, Goke M, Kanai M et al. Epithelial cell kinase-B61: An autocrine loop modulating intestinal epithelial migration and barrier function. Am J Physiol 1997; 273: G824–32.Google Scholar
  65. 65.
    Hess AR, Seftor EA, Gardner LM et al. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: Role of epithelial cell kinase (Ech/EphA2). Cancer Res 2001; 61: 3250–5.Google Scholar
  66. 66.
    Zantek ND, Zelinski DP, Peters MA et al. Estrogen and Myc Negatively Regulate Expression of the EphA2 Tyrosine Kinase. J Cell Physiol 2001.Google Scholar
  67. 67.
    Orsulic S, Kemler R. Expression of Eph receptors and ephrins is differentially regulated by E-cadherin. J Cell Sci 2000; 113: 1793–802.Google Scholar
  68. 68.
    Dohn M, Jiang J, Chen X. Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis. Oncogene 2001; 20: 6503–15.Google Scholar
  69. 69.
    Pandey A, Shao H, Marks RM et al. Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science 1995; 268: 567–9.Google Scholar
  70. 70.
    Pandey A, Duan H, Dixit VM. Characterization of a novel src-like adapter protein that associates with the Eck receptor tyrosine kinase. J Biol Chem 1995; 270: 19201–4.Google Scholar
  71. 71.
    Pandey A, Lazar DF, Saltiel AR et al. Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity. J Biol Chem 1994; 269: 30154–7.Google Scholar
  72. 72.
    Miao H, Wei B, Li Q et al. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol 2001; 3: 527–30.Google Scholar
  73. 73.
    Miao H, Burnett E, Kinch M et al. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat Cell Biol 2000; 2: 62–9.Google Scholar
  74. 74.
    Fagotto F, Gumbiner BM. Cell contact-dependent signaling. Dev Biol 1996; 180: 445–54.Google Scholar
  75. 75.
    Wieser RJ, Renauer D, Schafer A et al. Growth control in mammalian cells by cell-cell contacts. Environ Health Perspect 1990; 88: 251–3.Google Scholar
  76. 76.
    Miao H, Burnett E, Kinch MS et al. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat Cell Biol 2000; 2: 62–9.Google Scholar
  77. 77.
    Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285: 1028–32.Google Scholar
  78. 78.
    Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 1997; 9: 701–6.Google Scholar
  79. 79.
    van der Geer P, Pawson T. The PTB domain: A new protein module implicated in signal transduction. Trends Biochem Sci 1995; 20: 277–80.Google Scholar
  80. 80.
    Pawson T. Protein modules and signalling networks. Nature 1995; 373: 573–80.Google Scholar
  81. 81.
    Pratt RL, Kinch MS. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade. Oncogene 2002; In Press.Google Scholar
  82. 82.
    Dodelet VC, Pasquale EB. Eph receptors and ephrin ligands: Embryogenesis to tumorigenesis. Oncogene 2000; 19: 5614–9. (Review).Google Scholar
  83. 83.
    Potla L, Boghaert ER, Armellino D et al. Reduced expression of EphrinA1 (EFNA1) inhibits three-dimensional growth of HT29 colon carcinoma cells. Cancer Lett 2002; 175: 187–95.Google Scholar
  84. 84.
    Vleminckx K, Kemler R. Cadherins and tissue formation: Integrating adhesion and signaling. Bioessays 1999; 21: 211–20.Google Scholar
  85. 85.
    Yap AS, Brieher WM, Gumbiner BM. Molecular and functional analysis of cadherin-based adherens junctions. Ann Rev Cell Dev Biol 1997; 13: 119–46.Google Scholar
  86. 86.
    Birchmeier W, Behrens J, Weidner KM et al. Epithelial differentiation and the control of metastasis in carcinomas. Curr Top Microbiol Immunol 1996; 213: 117–35.Google Scholar
  87. 87.
    Cates CA, Michael RL, Stayrook KR et al. Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett 1996; 110: 49–55.Google Scholar
  88. 88.
    Carter P. Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 2001; 1: 118–29.Google Scholar
  89. 89.
    Maniotis AJ, Folberg R, Hess A et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999; 155: 739–52.Google Scholar
  90. 90.
    Bissell MJ. Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name? Am J Pathol 1999; 155: 675–9.Google Scholar
  91. 91.
    McCawley LJ, Matrisian LM. Matrix metalloproteinases: Multifunctional contributors to tumor progression. Mol Med Today 2000; 6: 149–56.Google Scholar
  92. 92.
    Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463–16.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Michael S. Kinch
    • 1
  • Kelly Carles-Kinch
    • 1
  1. 1.MedImmune, Inc.GaithersburgUSA

Personalised recommendations